Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2015, Article ID 296924, 4 pages
http://dx.doi.org/10.1155/2015/296924
Case Report

Nonclassical Congenital Adrenal Hyperplasia and Pregnancy

1Department of Endocrinology and Metabolism, Faculty of Medicine, Yildirim Beyazit University, 06800 Ankara, Turkey
2Department of Genetics, Dıskapı Yildirim Beyazit Education and Research Hospital, Ankara, Turkey

Received 5 August 2015; Accepted 28 September 2015

Academic Editor: Yuji Moriwaki

Copyright © 2015 Neslihan Cuhaci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Levine, “Congenital adrenal hyperplasia,” Pediatrics in Review, vol. 21, no. 5, pp. 159–171, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. I. N. Purwana, H. Kanasaki, A. Oride, and K. Miyazaki, “Successful pregnancy after the treatment of primary amenorrhea in a patient with non-classical congenital adrenal hyperplasia,” Journal of Obstetrics and Gynaecology Research, vol. 39, no. 1, pp. 406–409, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. P. W. Speiser, R. Azziz, L. S. Baskin et al., “Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp. 4133–4160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Krone, V. Dhir, H. E. Ivison, and W. Arlt, “Congenital adrenal hyperplasia and P450 oxidoreductase deficiency,” Clinical Endocrinology, vol. 66, no. 2, pp. 162–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. P. C. White and P. W. Speiser, “Congenital adrenal hyperplasia due to 21-hydroxylase deficiency,” Endocrine Reviews, vol. 21, no. 3, pp. 245–291, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. S. F. Witchel, “Non-classic congenital adrenal hyperplasia,” Steroids, vol. 78, no. 8, pp. 747–750, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Unluhizarci, M. Kula, M. Dundar et al., “The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism,” Gynecological Endocrinology, vol. 26, no. 2, pp. 139–143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Lekarev and M. I. New, “Adrenal disease in pregnancy,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 25, no. 6, pp. 959–973, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. F. Witchel, “Management of CAH during pregnancy: optimizing outcomes,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 19, no. 6, pp. 489–496, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Pinkas, S. Fuchs, Y. Klipper-Aurbach et al., “Non-classical 21-hydroxylase deficiency: prevalence in males with unexplained abnormal sperm analysis,” Fertility and Sterility, vol. 93, no. 6, pp. 1887–1891, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. C. Wilson, S. Nimkarn, M. Dumic et al., “Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency,” Molecular Genetics and Metabolism, vol. 90, no. 4, pp. 414–421, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. F. Witchel, “Nonclassic congenital adrenal hyperplasia,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 19, no. 3, pp. 151–158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Bidet, C. Bellanné-Chantelot, M.-B. Galand-Portier et al., “Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 3, pp. 1182–1190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. N. M. M. L. Stikkelbroeck, A. R. M. M. Hermus, D. D. M. Braat, and B. J. Otten, “Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency,” Obstetrical and Gynecological Survey, vol. 58, no. 4, pp. 275–284, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Moran, R. Azziz, N. Weintrob et al., “Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 9, pp. 3451–3456, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Feldman, L. Billaud, J.-C. Thalabard et al., “Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency,” Journal of Clinical Endocrinology and Metabolism, vol. 74, no. 3, pp. 635–639, 1992. View at Google Scholar · View at Scopus
  17. D. Dewailly, “Nonclassic 21-hydroxylase deficiency,” Seminars in Reproductive Medicine, vol. 20, no. 3, pp. 243–248, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Zinaman, E. D. Clegg, C. C. Brown, J. O'Connor, and S. G. Selevan, “Estimates of human fertility and pregnancy loss,” Fertility and Sterility, vol. 65, no. 3, pp. 503–509, 1996. View at Google Scholar · View at Scopus
  19. C. M. Trapp and S. E. Oberfield, “Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update,” Steroids, vol. 77, no. 4, pp. 342–346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. D. Birnbaum and L. I. Rose, “Late onset adrenocortical hydroxylase deficiencies associated with menstrual dysfunction,” Obstetrics and Gynecology, vol. 63, no. 4, pp. 445–451, 1984. View at Google Scholar · View at Scopus
  21. A. Augarten, R. Weissenberg, C. Pariente, and J. Sack, “Reversible male infertility in late onset congenital adrenal hyperplasia,” Journal of Endocrinological Investigation, vol. 14, no. 3, pp. 237–240, 1991. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Kalachanis, D. Rousso, A. Kourtis, F. Goutzioulis, G. Makedos, and D. Panidis, “Reversible infertility, pharmaceutical and spontaneous, in a male with late onset congenital adrenal hyperplasia, due to 21-hydroxylase deficiency,” Archives of Andrology, vol. 48, no. 1, pp. 37–41, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Bidet, C. Bellanné-Chantelot, M.-B. Galand-Portier et al., “Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 5, pp. 1570–1578, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. W. L. Miller and S. F. Witchel, “Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits,” American Journal of Obstetrics & Gynecology, vol. 208, no. 5, pp. 354–359, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Mercè Fernández-Balsells, K. Muthusamy, G. Smushkin et al., “Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses,” Clinical Endocrinology, vol. 73, no. 4, pp. 436–444, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. New, M. Abraham, T. Yuen, and O. Lekarev, “An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia,” Seminars in Reproductive Medicine, vol. 30, no. 5, pp. 396–399, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. I. New, Y. K. Tong, T. Yuen et al., “Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma,” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 6, pp. E1022–E1030, 2014. View at Publisher · View at Google Scholar · View at Scopus